Suppr超能文献

口服注射用维生素K

Administration of Injectable Vitamin K Orally.

作者信息

Afanasjeva Janna

机构信息

University of Illinois at Chicago, USA.

出版信息

Hosp Pharm. 2017 Oct;52(9):645-649. doi: 10.1177/0018578717729663. Epub 2017 Sep 8.

Abstract

Vitamin K, or phytonadione, is available in both injectable and oral formulations. Oral vitamin K is available as 5-mg tablets, but the key drawbacks for using vitamin K tablets consist of availability of only 1 dose strength and recent tripling of the product's cost over a 2-year period. An interest exists for utilization of injectable vitamin K via oral route. A literature search was performed on April 26, 2017, to identify any studies describing the use of injectable vitamin K for oral administration. The search involved PubMed and Embase and utilized various combinations of keywords , , , , , and . The results were limited to studies that discussed oral administration of injectable vitamin K. The efficacy of the injectable preparation of vitamin K administered orally was explored in 6 studies and one cost-savings project. Based on the available literature, the administration of injectable vitamin K via oral route is effective and safe. Injectable vitamin K for oral administration can be prepared as an undiluted solution or as a compounded solution. These 2 formulations have different beyond-use dates depending on ingredients used. Information on efficacy and stability of injectable vitamin K formulations prepared for oral administration provides an additional option for health care systems when vitamin K tablets are unavailable or cost-prohibitive to use.

摘要

维生素K,即叶绿醌,有注射剂和口服制剂两种形式。口服维生素K有5毫克片剂,但使用维生素K片剂的主要缺点包括只有一种剂量规格,且该产品成本在两年内上涨了两倍。人们对通过口服途径使用注射用维生素K存在兴趣。2017年4月26日进行了文献检索,以确定任何描述口服注射用维生素K的研究。检索涉及PubMed和Embase,并使用了各种关键词组合 , , , , ,和 。结果仅限于讨论口服注射用维生素K的研究。6项研究和一个成本节约项目探讨了口服注射用维生素K制剂的疗效。根据现有文献,通过口服途径给药的注射用维生素K是有效且安全的。口服注射用维生素K可制备成未稀释溶液或复合溶液。这两种制剂根据所用成分有不同的使用期限。当无法获得维生素K片剂或使用成本过高时,关于口服注射用维生素K制剂的疗效和稳定性信息为医疗保健系统提供了另一种选择。

相似文献

1
Administration of Injectable Vitamin K Orally.
Hosp Pharm. 2017 Oct;52(9):645-649. doi: 10.1177/0018578717729663. Epub 2017 Sep 8.
5
Oral administration of injectable vitamin K1 in brodifacoum intoxication.
Biomedicine (Taipei). 2022 Jun 1;12(2):47-49. doi: 10.37796/2211-8039.1305. eCollection 2022.
9
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
Arch Intern Med. 2006 Feb 27;166(4):391-7. doi: 10.1001/.391.

引用本文的文献

1
Pharmacokinetics of vitamin dosage forms: A complete overview.
Food Sci Nutr. 2023 Nov 9;12(1):48-83. doi: 10.1002/fsn3.3787. eCollection 2024 Jan.
2
Oral administration of injectable vitamin K1 in brodifacoum intoxication.
Biomedicine (Taipei). 2022 Jun 1;12(2):47-49. doi: 10.37796/2211-8039.1305. eCollection 2022.
3
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
J Pharm Technol. 2019 Jun;35(3):105-109. doi: 10.1177/8755122519838848. Epub 2019 Mar 29.

本文引用的文献

1
Phytonadione oral liquid.
Am J Health Syst Pharm. 2016 Jun 15;73(12):858-61. doi: 10.2146/ajhp160049.
2
Pharmacologic interventions for reversing the effects of oral anticoagulants.
Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.
3
An update of consensus guidelines for warfarin reversal.
Med J Aust. 2013 Mar 4;198(4):198-9. doi: 10.5694/mja12.10614.
5
Guidelines on oral anticoagulation with warfarin - fourth edition.
Br J Haematol. 2011 Aug;154(3):311-24. doi: 10.1111/j.1365-2141.2011.08753.x. Epub 2011 Jun 14.
6
Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
Br J Haematol. 2006 May;133(3):331-6. doi: 10.1111/j.1365-2141.2006.06029.x.
10
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
Lancet. 2000 Nov 4;356(9241):1551-3. doi: 10.1016/S0140-6736(00)03125-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验